A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants

Clinical trial NCT07723833 · RECRUITING

Trial details

NCT number: NCT07723833
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Participants

Start date: 2026-07-27
Primary completion: 2026-11-18
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.